Marcella J J, Nichols A B, Johnson L L, Owen J, Reison D S, Kaplan K L, Cannon P J
J Am Coll Cardiol. 1983 May;1(5):1185-93. doi: 10.1016/s0735-1097(83)80128-4.
The hypothesis that exercise-induced myocardial ischemia is associated with abnormal platelet activation and fibrin formation or dissolution was tested in patients with coronary artery disease undergoing upright bicycle stress testing. In vivo platelet activation was assessed by radioimmunoassay of platelet factor 4, beta-thrombo-globulin and thromboxane B2. In vivo fibrin formation was assessed by radioimmunoassay of fibrinopeptide A, and fibrinolysis was assessed by radioimmunoassay of thrombin-increasable fibrinopeptide B which reflects plasmin cleavage of fibrin I. Peripheral venous concentrations of these substances were measured in 10 normal subjects and 13 patients with coronary artery disease at rest and during symptom-limited peak exercise. Platelet factor 4, beta-thromboglobulin and thromboxane B2 concentrations were correlated with rest and exercise catecholamine concentrations to determine if exercise-induced elevation of norepinephrine and epinephrine enhances platelet activation. Left ventricular end-diastolic and end-systolic volumes, ejection fraction and segmental wall motion were measured at rest and during peak exercise by first pass radionuclide angiography. All patients with coronary artery disease had documented exercise-induced myocardial ischemia manifested by angina pectoris, ischemic electrocardiographic changes, left ventricular segmental dyssynergy and a reduction in ejection fraction. Rest and peak exercise plasma concentrations were not significantly different for platelet factor 4, beta-thromboglobulin, thromboxane B2, fibrinopeptide A and thrombin-increasable fibrinopeptide B. Peripheral venous concentrations of norepinephrine and epinephrine increased significantly (p less than 0.001) in both groups of patients. The elevated catecholamine levels did not lead to detectable platelet activation. This study demonstrates that enhanced platelet activation, thromboxane release and fibrin formation or dissolution are not detectable in peripheral venous blood of patients with coronary disease during exercise-induced myocardial ischemia.
在接受直立自行车运动负荷试验的冠心病患者中,对运动诱发的心肌缺血与血小板异常激活及纤维蛋白形成或溶解相关这一假说进行了验证。通过放射免疫分析法测定血小板因子4、β-血小板球蛋白和血栓素B2来评估体内血小板激活情况。通过放射免疫分析法测定纤维蛋白肽A来评估体内纤维蛋白形成情况,通过放射免疫分析法测定凝血酶可增加的纤维蛋白肽B(反映纤溶酶对纤维蛋白I的裂解)来评估纤维蛋白溶解情况。在10名正常受试者和13名冠心病患者静息时及症状限制的峰值运动期间,测量这些物质的外周静脉浓度。将血小板因子4、β-血小板球蛋白和血栓素B2浓度与静息和运动时的儿茶酚胺浓度进行相关性分析,以确定运动诱发的去甲肾上腺素和肾上腺素升高是否会增强血小板激活。通过首次通过放射性核素血管造影术在静息时和峰值运动期间测量左心室舒张末期和收缩末期容积、射血分数及节段性室壁运动。所有冠心病患者均有运动诱发心肌缺血的记录,表现为心绞痛、缺血性心电图改变、左心室节段性运动失调及射血分数降低。血小板因子4、β-血小板球蛋白、血栓素B2、纤维蛋白肽A和凝血酶可增加的纤维蛋白肽B的静息和峰值运动血浆浓度无显著差异。两组患者外周静脉去甲肾上腺素和肾上腺素浓度均显著升高(p<0.001)。儿茶酚胺水平升高并未导致可检测到的血小板激活。本研究表明,在运动诱发心肌缺血期间,冠心病患者外周静脉血中未检测到血小板激活增强、血栓素释放及纤维蛋白形成或溶解。